SMTL ID : 7wob.1

SARS-CoV-2 Spike in complex with IgG 553-60 (2-up trimer)

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-3-3-mer

Ligands

38 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 2 residues within 4Å: Chain A: Y.28, N.61 Ligand excluded by PLIP NAG.2: 7 residues within 4Å: Chain A: Q.115, C.131, E.132, N.164, N.165, C.166, T.167 Ligand excluded by PLIP NAG.3: 5 residues within 4Å: Chain A: N.196, G.232, I.233, N.234 Chain C: H.519 Ligand excluded by PLIP NAG.4: 2 residues within 4Å: Chain A: N.282 Chain C: K.558 Ligand excluded by PLIP NAG.5: 2 residues within 4Å: Chain A: N.331, Q.580 Ligand excluded by PLIP NAG.6: 3 residues within 4Å: Chain A: F.338, G.339, N.343 Ligand excluded by PLIP NAG.7: 1 residues within 4Å: Chain A: N.616 Ligand excluded by PLIP NAG.8: 2 residues within 4Å: Chain A: N.709, G.1131 Ligand excluded by PLIP NAG.9: 4 residues within 4Å: Chain A: N.717, L.922, Q.926, Q.1071 Ligand excluded by PLIP NAG.10: 3 residues within 4Å: Chain A: N.801, S.803, Q.804 Ligand excluded by PLIP NAG.11: 4 residues within 4Å: Chain A: A.706, E.1072, K.1073, N.1074 Ligand excluded by PLIP NAG.12: 4 residues within 4Å: Chain A: N.1098, T.1100, H.1101, F.1103 Ligand excluded by PLIP NAG.13: 2 residues within 4Å: Chain A: H.1083, N.1134 Ligand excluded by PLIP NAG.14: 2 residues within 4Å: Chain B: N.30, N.61 Ligand excluded by PLIP NAG.15: 3 residues within 4Å: Chain B: A.163, N.164, N.165 Ligand excluded by PLIP NAG.16: 3 residues within 4Å: Chain B: T.108, N.234, T.236 Ligand excluded by PLIP NAG.17: 3 residues within 4Å: Chain A: K.558 Chain B: N.280, N.282 Ligand excluded by PLIP NAG.18: 2 residues within 4Å: Chain B: N.331, Q.580 Ligand excluded by PLIP NAG.19: 5 residues within 4Å: Chain B: F.338, G.339, F.342, N.343, L.368 Ligand excluded by PLIP NAG.20: 2 residues within 4Å: Chain B: N.616, Q.644 Ligand excluded by PLIP NAG.21: 2 residues within 4Å: Chain B: N.709, G.1131 Ligand excluded by PLIP NAG.22: 3 residues within 4Å: Chain B: N.717, L.922, Q.926 Ligand excluded by PLIP NAG.23: 3 residues within 4Å: Chain B: N.801, S.803, Q.804 Ligand excluded by PLIP NAG.24: 2 residues within 4Å: Chain B: N.1074, F.1075 Ligand excluded by PLIP NAG.25: 4 residues within 4Å: Chain B: N.1098, T.1100, H.1101, F.1103 Ligand excluded by PLIP NAG.26: 1 residues within 4Å: Chain B: N.1134 Ligand excluded by PLIP NAG.27: 3 residues within 4Å: Chain C: Y.28, T.29, N.61 Ligand excluded by PLIP NAG.28: 3 residues within 4Å: Chain C: Q.115, N.164, N.165 Ligand excluded by PLIP NAG.29: 3 residues within 4Å: Chain B: H.519 Chain C: G.232, N.234 Ligand excluded by PLIP NAG.30: 3 residues within 4Å: Chain C: N.280, E.281, N.282 Ligand excluded by PLIP NAG.31: 2 residues within 4Å: Chain C: N.331, Q.580 Ligand excluded by PLIP NAG.32: 1 residues within 4Å: Chain C: N.616 Ligand excluded by PLIP NAG.33: 3 residues within 4Å: Chain C: S.708, N.709, N.710 Ligand excluded by PLIP NAG.34: 3 residues within 4Å: Chain C: N.717, L.922, Q.926 Ligand excluded by PLIP NAG.35: 3 residues within 4Å: Chain C: N.801, S.803, Q.804 Ligand excluded by PLIP NAG.36: 3 residues within 4Å: Chain C: N.1074, F.1075, T.1076 Ligand excluded by PLIP NAG.37: 4 residues within 4Å: Chain C: N.1098, T.1100, H.1101, F.1103 Ligand excluded by PLIP NAG.38: 1 residues within 4Å: Chain C: N.1134 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhan, W. et al., Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer. J.Virol. (2022)

Release Date

2022-07-20

Peptides

Spike glycoprotein: ABC
mAb60 VH: DFH
mAb60 VL: EGI

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

C
E

D
D

F
F

H
H

E
B

G
G

I
I

Spike glycoprotein

mAb60 VH

mAb60 VL

Related Entries With Identical Sequence